retatrutide clinical trial updates parkinson's disease drug therapies in the pipeline: 2024 update Triple hormone receptor agonist retatrutide – Retatrutide, an investigational triple hormone
Pay in 4 interest-free payments of $5.42 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24



























